Design, synthesis and evaluation of novel nonquaternary and 3 non-oxime reactivators for acetylcholinesterase inhibited by organophosphates.


Journal

Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703

Informations de publication

Date de publication:
07 2020
Historique:
received: 17 10 2019
revised: 28 04 2020
accepted: 29 04 2020
pubmed: 11 5 2020
medline: 4 3 2021
entrez: 11 5 2020
Statut: ppublish

Résumé

A new series of novel nonquaternary conjugates and non-oxime reactivators for reactivation of both nerve agents and pesticides inhibited hAChE were described in this paper. Conjugates with piperazine linked to the substituted salicylaldoxime emerged as efficient reactivators for VX inhibited hAChE. The in vitro reactivation experiment showed that some of them were equal or more efficient reactivators for pesticides inhibited hAChE than obidoxime. It was also found that some non-oxime derivatives of Mannich phenols displayed obvious reactivation potency for VX, sarin and pesticides inhibited hAChE even in very low concentration. It has been proved that introduction of peripheral site ligands with widespread aromatic system and amide substitutions could increase binding affinity for inhibited hAChE in most cases, which contribute to the reactivation efficiency.

Identifiants

pubmed: 32388435
pii: S0045-2068(19)31751-1
doi: 10.1016/j.bioorg.2020.103902
pii:
doi:

Substances chimiques

Cholinesterase Inhibitors 0
Cholinesterase Reactivators 0
Nerve Agents 0
Organophosphates 0
Oximes 0
Pesticides 0
Piperazine 1RTM4PAL0V
salicylaldoxime 2QTV2A0T5Q
Acetylcholinesterase EC 3.1.1.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103902

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declared that there is no conflict of interest.

Auteurs

Huanglei Bi (H)

Laboratory of Computer-Aided Drug Design & Discovery, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; Department of Pharmacy, The 969th Hospital of the joint logistics support force of PLA, Hohhot 010051, China.

Qin Ouyang (Q)

College of Pharmacy, Third Military Medical University, Shapingba, Chongqing, 400038, China.

Zhao Wei (Z)

Department of Medicinal and analytical Chemistry, School of Pharmacy, Fourth Military Medical University, Xi'an 300071, China. Electronic address: weizhaobruce@163.com.

Zhibing Zheng (Z)

Laboratory of Computer-Aided Drug Design & Discovery, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China. Electronic address: zzbcaptain@aliyun.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH